Cargando…
Dosage Mutator Genes in Saccharomyces cerevisiae: A Novel Mutator Mode-of-Action of the Mph1 DNA Helicase
Mutations that cause genome instability are considered important predisposing events that contribute to initiation and progression of cancer. Genome instability arises either due to defects in genes that cause an increased mutation rate (mutator phenotype), or defects in genes that cause chromosome...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Genetics Society of America
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105872/ https://www.ncbi.nlm.nih.gov/pubmed/27585847 http://dx.doi.org/10.1534/genetics.116.192211 |
_version_ | 1782466962188664832 |
---|---|
author | Ang, J. Sidney Duffy, Supipi Segovia, Romulo Stirling, Peter C. Hieter, Philip |
author_facet | Ang, J. Sidney Duffy, Supipi Segovia, Romulo Stirling, Peter C. Hieter, Philip |
author_sort | Ang, J. Sidney |
collection | PubMed |
description | Mutations that cause genome instability are considered important predisposing events that contribute to initiation and progression of cancer. Genome instability arises either due to defects in genes that cause an increased mutation rate (mutator phenotype), or defects in genes that cause chromosome instability (CIN). To extend the catalog of genome instability genes, we systematically explored the effects of gene overexpression on mutation rate, using a forward-mutation screen in budding yeast. We screened ∼5100 plasmids, each overexpressing a unique single gene, and characterized the five strongest mutators, MPH1 (mutator phenotype 1), RRM3, UBP12, PIF1, and DNA2. We show that, for MPH1, the yeast homolog of Fanconi Anemia complementation group M (FANCM), the overexpression mutator phenotype is distinct from that of mph1Δ. Moreover, while four of our top hits encode DNA helicases, the overexpression of 48 other DNA helicases did not cause a mutator phenotype, suggesting this is not a general property of helicases. For Mph1 overexpression, helicase activity was not required for the mutator phenotype; in contrast Mph1 DEAH-box function was required for hypermutation. Mutagenesis by MPH1 overexpression was independent of translesion synthesis (TLS), but was suppressed by overexpression of RAD27, a conserved flap endonuclease. We propose that binding of DNA flap structures by excess Mph1 may block Rad27 action, creating a mutator phenotype that phenocopies rad27Δ. We believe this represents a novel mutator mode-of-action and opens up new prospects to understand how upregulation of DNA repair proteins may contribute to mutagenesis. |
format | Online Article Text |
id | pubmed-5105872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Genetics Society of America |
record_format | MEDLINE/PubMed |
spelling | pubmed-51058722016-11-14 Dosage Mutator Genes in Saccharomyces cerevisiae: A Novel Mutator Mode-of-Action of the Mph1 DNA Helicase Ang, J. Sidney Duffy, Supipi Segovia, Romulo Stirling, Peter C. Hieter, Philip Genetics Investigations Mutations that cause genome instability are considered important predisposing events that contribute to initiation and progression of cancer. Genome instability arises either due to defects in genes that cause an increased mutation rate (mutator phenotype), or defects in genes that cause chromosome instability (CIN). To extend the catalog of genome instability genes, we systematically explored the effects of gene overexpression on mutation rate, using a forward-mutation screen in budding yeast. We screened ∼5100 plasmids, each overexpressing a unique single gene, and characterized the five strongest mutators, MPH1 (mutator phenotype 1), RRM3, UBP12, PIF1, and DNA2. We show that, for MPH1, the yeast homolog of Fanconi Anemia complementation group M (FANCM), the overexpression mutator phenotype is distinct from that of mph1Δ. Moreover, while four of our top hits encode DNA helicases, the overexpression of 48 other DNA helicases did not cause a mutator phenotype, suggesting this is not a general property of helicases. For Mph1 overexpression, helicase activity was not required for the mutator phenotype; in contrast Mph1 DEAH-box function was required for hypermutation. Mutagenesis by MPH1 overexpression was independent of translesion synthesis (TLS), but was suppressed by overexpression of RAD27, a conserved flap endonuclease. We propose that binding of DNA flap structures by excess Mph1 may block Rad27 action, creating a mutator phenotype that phenocopies rad27Δ. We believe this represents a novel mutator mode-of-action and opens up new prospects to understand how upregulation of DNA repair proteins may contribute to mutagenesis. Genetics Society of America 2016-11 2016-08-31 /pmc/articles/PMC5105872/ /pubmed/27585847 http://dx.doi.org/10.1534/genetics.116.192211 Text en Copyright © 2016 by the Genetics Society of America Available freely online through the author-supported open access option. |
spellingShingle | Investigations Ang, J. Sidney Duffy, Supipi Segovia, Romulo Stirling, Peter C. Hieter, Philip Dosage Mutator Genes in Saccharomyces cerevisiae: A Novel Mutator Mode-of-Action of the Mph1 DNA Helicase |
title | Dosage Mutator Genes in Saccharomyces cerevisiae: A Novel Mutator Mode-of-Action of the Mph1 DNA Helicase |
title_full | Dosage Mutator Genes in Saccharomyces cerevisiae: A Novel Mutator Mode-of-Action of the Mph1 DNA Helicase |
title_fullStr | Dosage Mutator Genes in Saccharomyces cerevisiae: A Novel Mutator Mode-of-Action of the Mph1 DNA Helicase |
title_full_unstemmed | Dosage Mutator Genes in Saccharomyces cerevisiae: A Novel Mutator Mode-of-Action of the Mph1 DNA Helicase |
title_short | Dosage Mutator Genes in Saccharomyces cerevisiae: A Novel Mutator Mode-of-Action of the Mph1 DNA Helicase |
title_sort | dosage mutator genes in saccharomyces cerevisiae: a novel mutator mode-of-action of the mph1 dna helicase |
topic | Investigations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105872/ https://www.ncbi.nlm.nih.gov/pubmed/27585847 http://dx.doi.org/10.1534/genetics.116.192211 |
work_keys_str_mv | AT angjsidney dosagemutatorgenesinsaccharomycescerevisiaeanovelmutatormodeofactionofthemph1dnahelicase AT duffysupipi dosagemutatorgenesinsaccharomycescerevisiaeanovelmutatormodeofactionofthemph1dnahelicase AT segoviaromulo dosagemutatorgenesinsaccharomycescerevisiaeanovelmutatormodeofactionofthemph1dnahelicase AT stirlingpeterc dosagemutatorgenesinsaccharomycescerevisiaeanovelmutatormodeofactionofthemph1dnahelicase AT hieterphilip dosagemutatorgenesinsaccharomycescerevisiaeanovelmutatormodeofactionofthemph1dnahelicase |